Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ)
CNY 70.63
(-0.16%)
CNY 70.63
(-0.16%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 240.03 Million CNY | 13.39% |
| 2022 | 211.68 Million CNY | 8.72% |
| 2021 | 194.7 Million CNY | 121.31% |
| 2020 | 87.97 Million CNY | 145.11% |
| 2019 | 35.89 Million CNY | 162.79% |
| 2018 | 13.65 Million CNY | -65.37% |
| 2017 | 39.43 Million CNY | -27.34% |
| 2016 | 54.27 Million CNY | 146.95% |
| 2015 | 21.97 Million CNY | -29.12% |
| 2014 | 31.01 Million CNY | -32.73% |
| 2013 | 46.09 Million CNY | 5.48% |
| 2012 | 43.7 Million CNY | 22.64% |
| 2011 | 35.63 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 34.74 Million CNY | -39.78% |
| 2024 Q2 | 134.57 Million CNY | 287.27% |
| 2024 Q3 | 121.44 Million CNY | -9.76% |
| 2023 Q2 | 68.4 Million CNY | 253.53% |
| 2023 Q1 | 19.34 Million CNY | 118.73% |
| 2023 FY | 240.03 Million CNY | 13.39% |
| 2023 Q3 | 94.57 Million CNY | 38.26% |
| 2023 Q4 | 57.7 Million CNY | -38.99% |
| 2022 FY | 211.68 Million CNY | 8.72% |
| 2022 Q2 | 46.46 Million CNY | -37.35% |
| 2022 Q1 | 74.16 Million CNY | 92.01% |
| 2022 Q4 | 8.84 Million CNY | -89.24% |
| 2022 Q3 | 82.2 Million CNY | 76.92% |
| 2021 FY | 194.7 Million CNY | 121.31% |
| 2021 Q2 | 46.93 Million CNY | 41.33% |
| 2021 Q3 | 75.93 Million CNY | 61.8% |
| 2021 Q4 | 38.62 Million CNY | -49.13% |
| 2021 Q1 | 33.2 Million CNY | -3.03% |
| 2020 Q4 | 34.24 Million CNY | -10.87% |
| 2020 Q3 | 38.41 Million CNY | 49.21% |
| 2020 FY | 87.97 Million CNY | 145.11% |
| 2020 Q2 | 25.74 Million CNY | 346.77% |
| 2020 Q1 | -10.43 Million CNY | -242.1% |
| 2019 Q4 | 7.34 Million CNY | -67.83% |
| 2019 Q2 | 4.66 Million CNY | 338.93% |
| 2019 Q1 | 1.06 Million CNY | 129.96% |
| 2019 FY | 35.89 Million CNY | 162.79% |
| 2019 Q3 | 22.82 Million CNY | 389.46% |
| 2018 Q3 | 15.07 Million CNY | 2127.85% |
| 2018 FY | 13.65 Million CNY | -65.37% |
| 2018 Q4 | 461.99 Thousand CNY | -96.94% |
| 2018 Q2 | 676.82 Thousand CNY | 126.45% |
| 2018 Q1 | -2.55 Million CNY | -5.68% |
| 2017 FY | 39.43 Million CNY | -27.34% |
| 2017 Q4 | -2.42 Million CNY | -118.38% |
| 2017 Q2 | 20.15 Million CNY | 136.45% |
| 2017 Q1 | 8.52 Million CNY | -4.23% |
| 2017 Q3 | 13.17 Million CNY | -34.64% |
| 2016 FY | 54.27 Million CNY | 146.95% |
| 2016 Q1 | 7.48 Million CNY | 0.0% |
| 2016 Q2 | 24.56 Million CNY | 228.27% |
| 2016 Q3 | 13.33 Million CNY | -45.71% |
| 2016 Q4 | 8.9 Million CNY | -33.24% |
| 2015 FY | 21.97 Million CNY | -29.12% |
| 2014 FY | 31.01 Million CNY | -32.73% |
| 2014 Q4 | 10.51 Million CNY | 0.0% |
| 2013 FY | 46.09 Million CNY | 5.48% |
| 2012 FY | 43.7 Million CNY | 22.64% |
| 2011 FY | 35.63 Million CNY | 0.0% |